(a) Each Retail Pharmacy shall maintain a pharmaceutical stock of Opioid Antagonists sufficient to fill at least two purchases of Opioid Antagonists by consumers.
(b) The following shall constitute a sufficient stock of Opioid Antagonist for purposes of this Section 4803: (1) two boxes of nonprescription Opioid Antagonist; (2) two boxes of prescription Opioid Antagonist; or (3) one box of prescription Opioid Antagonist and one box of nonprescription Opioid Antagonist.
(c) It shall be an affirmative defense to a violation of subsection (a) of this Section 4803 for a Retail Pharmacy to demonstrate by a preponderance of the evidence that:
(1) No more than three days had elapsed since the Retail Pharmacy maintained a pharmaceutical stock of Opioid Antagonists sufficient to fill at least two requests for Opioid Antagonists; and
(2) During that three-day grace period, the Retail Pharmacy had ordered replacement stock and was waiting for the supplier or wholesaler to fill the order.
(d) Retail Pharmacies shall post clear and legible signage advising customers of the availability of Opioid Antagonists at the following locations:
(1) At all points of sale at which a Pharmacist dispenses pharmaceuticals; and
(2) If the Retail Pharmacy stocks nonprescription, over-the-counter Opioid Antagonists, at all points of sale where the Retail Pharmacy sells nonprescription medication.
(e) The Department may develop model signage for use by Retail Pharmacies.